GE Healthcare is launching a ready-to-run factory-in-a-box to speed up the production of viral vector based therapeutics...
Shire, a leading global biotechnology company focused on rare diseases is selling its oncology business to French drugma...
Singapore - In a study of more than 15,000 girls and their mothers — all Kaiser Permanente members in Norther...
Singapore – Nine major Italian federations representing sectors from fashion to healthcare and technology, arrived...
A group of scientists at the University of Bath has created a non-invasive adhesive patch that promises the measure...
Merck, a leading science and technology company has announced a partnership with Oxford University’s Jenner I...
Singapore- Sanofi is investing €350M (CAD $500M) to construct a new state-of-art vaccine manufacturing facilit...
Mylan and Biocon have agreed to accelerate introduction of adalimumab biosimilar in Europe through Mylan’s in-lice...
Singapore- Boston Therapeutics inks a non-binding letter of intent with Medical Technology Associates to acqui...
Singapore- Woburn, MA-based Abpro Therapeutics (ABP) has filed a preliminary prospectus for a $69M I...
Singapore- Vermillion, a bio-analytical solutions company focused on gynecologic disease, announced that it intends to o...
Singapore- A new peer-reviewed, published study shows that natural French maritime pine bark extract Pycnogenol is effec...
Singapore - Abbott announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo st...
Singapore - GSK and Orchard Therapeutics signs a strategic agreement, under which GSK will transfer its p...
Singapore - Under its De Novo (no predicate product) review pathway, the FDA approves the first medical device in t...
Singapore - Genesis HealthCare, one of the largest post-acute care providers in the United States, today announced it ha...
M&A deal making continues with Alexion Pharmaceuticals swapping up Wilson Therapeutics AB for USD 855 millio...
Singapore - Zealand Pharma and Roche’s Diabetes Care unit will partner on Phase 3 clinical trials assess...
